Build status - In Progress

A Study to Evaluate LTI-01 in Patients With Infected, Non-draining Pleural Effusions

Recruiting
18 years - 99 years
All
Phase 2
6 participants needed
1 Location

Brief description of study

The LTI-01-2001 study is a double-blind, placebo-controlled, Phase 2 study to evaluate LTI-01 (single-chain urokinase plasminogen activator, scuPA) in patients with infected, non-draining pleural effusions.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: Pleural Effusion
  • Age: 18 years - 99 years
  • Gender: All

Male or Female, Age 18 or older, Pleural Effusions

Updated on 04 Aug 2024. Study ID: 842674

Find a site

We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Preferred way of contact
Race
Ethnicity
Other language

Interested in the study

Select a study center that’s convenient for you, and get in touch with the study team.

Contact a study center